FDA Inspection 912599 — Alejandro (NMI) Hoberman, M.D.
The FDA completed an inspection of Alejandro (NMI) Hoberman, M.D. on February 4, 2015 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 4, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Pittsburgh, PA (United States)
Additional Details
Clinical Investigator (CI)